Davis-based infant nutrition company Evolve BioSystems Inc. this week closed a $65 million round of funding that will allow it to expand commercialization of its products, hire more employees, market its products, raise awareness of infant gut deficiency problems and to create new forms of its products, CEO Timothy Brown told the Business Journal.
Evolve Biosystems is a California-based biotechnology firm that develops and commercializes microbiome-based therapeutics for the treatment of infant gut health problems.